According to our hypothesis, we found that LDHi enhances the activity of CTLA-4 blockade in delaying B16 and MC38 tumor growth, with greater antitumor effects of the combination than each treatment alone (Figure 6A and Supplemental Figure 7A). This evidence concerns the gene CTLA4 and neoplasm.